Down-Regulation of CTLA-4 by HIV-1 Nef Protein

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  El Far, Mohamed ^a,b,i   Isabelle, Catherine ^a,b   Chomont, Nicolas ^a,b,c   Bourbonnière, Martin ^a,b   Fonseca, Simone ^a,b,c,j   Ancuta, Petronela ^a   Peretz, Yoav ^a,b   Chouikh, Younes ^a,b   Halwani, Rabih ^d   Schwartz, Olivier ^e   Madrenas, Joaquín ^f   Freeman, Gordon J ^g   Routy, Jean Pierre ^h   Haddad, Elias K ^a,b,c   Sékaly, Rafick Pierre ^a,b,c  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c Vaccine and Gene Therapy Institute of Florida   (United States)

^d KING SAUD UNIVERSITY   (Saudi Arabia)

^e INSTITUT PASTEUR   (France)

^f MCGILL UNIVERSITY   (Canada)

^g HARVARD MEDICAL SCHOOL   (United States)

^h ROYAL VICTORIA HOSPITAL   (Canada)

ⁱ BOEHRINGER INGELHEIM CANADA LTD   (Canada)

^j FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; NEF PROTEIN;

ARTICLE; CELL SURFACE; CONTROLLED STUDY; DOWN REGULATION; ENDOSOME; HUMAN IMMUNODEFICIENCY VIRUS 1; LYSOSOME; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN MOTIF; T LYMPHOCYTE ACTIVATION;

AMINO ACID MOTIFS; ANTIGENS, CD4; CTLA-4 ANTIGEN; DOWN-REGULATION; ENDOCYTOSIS; ENDOSOMES; HEK293 CELLS; HELA CELLS; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; LYSOSOMES; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; TRANSFECTION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84872804428     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054295     Document Type: Article

References (63)

1. Malim MH, Emerman M, (2008) HIV-1 accessory proteins-ensuring viral survival in a hostile environment. Cell Host Microbe 3: 388-398.
2. Aiken C, Konner J, Landau NR, Lenburg ME, Trono D, (1994) Nef induces CD4 endocytosis: requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell 76: 853-864.
3. Arold ST, Baur AS, (2001) Dynamic Nef and Nef dynamics: how structure could explain the complex activities of this small HIV protein. Trends Biochem Sci 26: 356-363.
4. Benichou S, Bomsel M, Bodeus M, Durand H, Doute M, et al. (1994) Physical interaction of the HIV-1 Nef protein with beta-COP, a component of non-clathrin-coated vesicles essential for membrane traffic. J Biol Chem 269: 30073-30076.
5. Chen BK, Gandhi RT, Baltimore D, (1996) CD4 down-modulation during infection of human T cells with human immunodeficiency virus type 1 involves independent activities of vpu, env, and nef. J Virol 70: 6044-6053.
6. Bresnahan PA, Yonemoto W, Ferrell S, Williams-Herman D, Geleziunas R, et al. (1998) A dileucine motif in HIV-1 Nef acts as an internalization signal for CD4 downregulation and binds the AP-1 clathrin adaptor. Curr Biol 8: 1235-1238.
7. Faure J, Stalder R, Borel C, Sobo K, Piguet V, et al. (2004) ARF1 regulates Nef-induced CD4 degradation. Curr Biol 14: 1056-1064.
8. Lundquist CA, Tobiume M, Zhou J, Unutmaz D, Aiken C, (2002) Nef-mediated downregulation of CD4 enhances human immunodeficiency virus type 1 replication in primary T lymphocytes. J Virol 76: 4625-4633.
9. Piguet V, Trono D, (1999) The Nef protein of primate lentiviruses. Rev Med Virol 9: 111-120.
10. Schwartz O, Marechal V, Le Gall S, Lemonnier F, Heard JM, (1996) Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat Med 2: 338-342.
11. Linnemann T, Zheng YH, Mandic R, Peterlin BM, (2002) Interaction between Nef and phosphatidylinositol-3-kinase leads to activation of p21-activated kinase and increased production of HIV. Virology 294: 246-255.
12. Arora VK, Molina RP, Foster JL, Blakemore JL, Chernoff J, et al. (2000) Lentivirus Nef specifically activates Pak2. J Virol 74: 11081-11087.
13. Wolf D, Witte V, Laffert B, Blume K, Stromer E, et al. (2001) HIV-1 Nef associated PAK and PI3-kinases stimulate Akt-independent Bad-phosphorylation to induce anti-apoptotic signals. Nat Med 7: 1217-1224.
14. Lee CH, Saksela K, Mirza UA, Chait BT, Kuriyan J, (1996) Crystal structure of the conserved core of HIV-1 Nef complexed with a Src family SH3 domain. Cell 85: 931-942.
15. Collette Y, Dutartre H, Benziane A, Ramos M, Benarous R, et al. (1996) Physical and functional interaction of Nef with Lck. HIV-1 Nef-induced T-cell signaling defects. J Biol Chem 271: 6333-6341.
16. Lee CH, Leung B, Lemmon MA, Zheng J, Cowburn D, et al. (1995) A single amino acid in the SH3 domain of Hck determines its high affinity and specificity in binding to HIV-1 Nef protein. EMBO J 14: 5006-5015.
17. Wu Y, Marsh JW, (2001) Selective transcription and modulation of resting T cell activity by preintegrated HIV DNA. Science 293: 1503-1506.
18. Schrager JA, Marsh JW, (1999) HIV-1 Nef increases T cell activation in a stimulus-dependent manner. Proc Natl Acad Sci U S A 96: 8167-8172.
19. Kroczek RA, Mages HW, Hutloff A, (2004) Emerging paradigms of T-cell co-stimulation. Curr Opin Immunol 16: 321-327.
20. Waterhouse P, Penninger JM, Timms E, Wakeham A, Shahinian A, et al. (1995) Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270: 985-988.
21. Carreno BM, Bennett F, Chau TA, Ling V, Luxenberg D, et al. (2000) CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression. J Immunol 165: 1352-1356.
22. Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T, Miyara M, et al. (2008) CTLA-4 control over Foxp3+ regulatory T cell function. Science 322: 271-275.
23. Munn DH, Sharma MD, Mellor AL, (2004) Ligation of B7-1/B7-2 by human CD4+ T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells. J Immunol 172: 4100-4110.
24. Leung HT, Bradshaw J, Cleaveland JS, Linsley PS, (1995) Cytotoxic T lymphocyte-associated molecule-4, a high-avidity receptor for CD80 and CD86, contains an intracellular localization motif in its cytoplasmic tail. J Biol Chem 270: 25107-25114.
25. Linsley PS, Bradshaw J, Greene J, Peach R, Bennett KL, et al. (1996) Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement. Immunity 4: 535-543.
26. Chuang E, Lee KM, Robbins MD, Duerr JM, Alegre ML, et al. (1999) Regulation of cytotoxic T lymphocyte-associated molecule-4 by Src kinases. J Immunol 162: 1270-1277.
27. Krummel MF, Allison JP, (1996) CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J Exp Med 183: 2533-2540.
28. Guntermann C, Alexander DR, (2002) CTLA-4 suppresses proximal TCR signaling in resting human CD4(+) T cells by inhibiting ZAP-70 Tyr(319) phosphorylation: a potential role for tyrosine phosphatases. J Immunol 168: 4420-4429.
29. Harlin H, Hwang KW, Palucki DA, Kim O, Thompson CB, et al. (2002) CTLA-4 engagement regulates NF-kappaB activation in vivo. Eur J Immunol 32: 2095-2104.
30. Bachelerie F, Alcami J, Hazan U, Israel N, Goud B, et al. (1990) Constitutive expression of human immunodeficiency virus (HIV) nef protein in human astrocytes does not influence basal or induced HIV long terminal repeat activity. J Virol 64: 3059-3062.
31. Jordan M, Schallhorn A, Wurm FM, (1996) Transfecting mammalian cells: optimization of critical parameters affecting calcium-phosphate precipitate formation. Nucleic Acids Res 24: 596-601.
32. Manders EM, Stap J, Brakenhoff GJ, van Driel R, Aten JA, (1992) Dynamics of three-dimensional replication patterns during the S-phase, analysed by double labelling of DNA and confocal microscopy. J Cell Sci 103 (Pt 3):: 857-862.
33. Tseng SY, Waite JC, Liu M, Vardhana S, Dustin ML, (2008) T cell-dendritic cell immunological synapses contain TCR-dependent CD28-CD80 clusters that recruit protein kinase C theta. J Immunol 181: 4852-4863.
34. Chun T, Choi HJ, Chung YH, (2004) Two different forms of human CTLA-4 proteins following peripheral T cell activation. Immunol Lett 91: 213-220.
35. Shiratori T, Miyatake S, Ohno H, Nakaseko C, Isono K, et al. (1997) Tyrosine phosphorylation controls internalization of CTLA-4 by regulating its interaction with clathrin-associated adaptor complex AP-2. Immunity 6: 583-589.
36. Zhang Y, Allison JP, (1997) Interaction of CTLA-4 with AP50, a clathrin-coated pit adaptor protein. Proc Natl Acad Sci U S A 94: 9273-9278.
37. Mead KI, Zheng Y, Manzotti CN, Perry LC, Liu MK, et al. (2005) Exocytosis of CTLA-4 is dependent on phospholipase D and ADP ribosylation factor-1 and stimulated during activation of regulatory T cells. J Immunol 174: 4803-4811.
38. Fackler OT, Moris A, Tibroni N, Giese SI, Glass B, et al. (2006) Functional characterization of HIV-1 Nef mutants in the context of viral infection. Virology 351: 322-339.
39. Stevens TH, Forgac M, (1997) Structure, function and regulation of the vacuolar (H+)-ATPase. Annu Rev Cell Dev Biol 13: 779-808.
40. Peter F, Plutner H, Zhu H, Kreis TE, Balch WE, (1993) Beta-COP is essential for transport of protein from the endoplasmic reticulum to the Golgi in vitro. J Cell Biol 122: 1155-1167.
41. Mindell JA, (2012) Lysosomal acidification mechanisms. Annu Rev Physiol 74: 69-86.
42. Huss M, Ingenhorst G, Konig S, Gassel M, Drose S, et al. (2002) Concanamycin A, the specific inhibitor of V-ATPases, binds to the V(o) subunit c. J Biol Chem 277: 40544-40548.
43. Maxfield FR, (1982) Weak bases and ionophores rapidly and reversibly raise the pH of endocytic vesicles in cultured mouse fibroblasts. J Cell Biol 95: 676-681.
44. Ohkuma S, Poole B, (1978) Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents. Proc Natl Acad Sci U S A 75: 3327-3331.
45. Jeong JY, Choi JW, Jeon KI, Jue DM, (2002) Chloroquine decreases cell-surface expression of tumour necrosis factor receptors in human histiocytic U-937 cells. Immunology 105: 83-91.
46. Luo T, Anderson SJ, Garcia JV, (1996) Inhibition of Nef- and phorbol ester-induced CD4 degradation by macrolide antibiotics. J Virol 70: 1527-1534.
47. Duprez V, Smoljanovic M, Lieb M, Dautry-Varsat A, (1994) Trafficking of interleukin 2 and transferrin in endosomal fractions of T lymphocytes. J Cell Sci 107 (Pt 5):: 1289-1295.
48. Alegre ML, Noel PJ, Eisfelder BJ, Chuang E, Clark MR, et al. (1996) Regulation of surface and intracellular expression of CTLA4 on mouse T cells. J Immunol 157: 4762-4770.
49. Cluet D, Bertsch C, Beyer C, Gloeckler L, Erhardt M, et al. (2005) Detection of human immunodeficiency virus type 1 Nef and CD4 physical interaction in living human cells by using bioluminescence resonance energy transfer. J Virol 79: 8629-8636.
50. Kaufmann DE, Kavanagh DG, Pereyra F, Zaunders JJ, Mackey EW, et al. (2007) Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction. Nat Immunol 8: 1246-1254.
51. Leng Q, Bentwich Z, Magen E, Kalinkovich A, Borkow G, (2002) CTLA-4 upregulation during HIV infection: association with anergy and possible target for therapeutic intervention. AIDS 16: 519-529.
52. Garcia JV, Miller AD, (1991) Serine phosphorylation-independent downregulation of cell-surface CD4 by nef. Nature 350: 508-511.
53. Harris MP, Neil JC, (1994) Myristoylation-dependent binding of HIV-1 Nef to CD4. J Mol Biol 241: 136-142.
54. Hua J, Blair W, Truant R, Cullen BR, (1997) Identification of regions in HIV-1 Nef required for efficient downregulation of cell surface CD4. Virology 231: 231-238.
55. Lu X, Yu H, Liu SH, Brodsky FM, Peterlin BM, (1998) Interactions between HIV1 Nef and vacuolar ATPase facilitate the internalization of CD4. Immunity 8: 647-656.
56. Liu LX, Heveker N, Fackler OT, Arold S, Le Gall S, et al. (2000) Mutation of a conserved residue (D123) required for oligomerization of human immunodeficiency virus type 1 Nef protein abolishes interaction with human thioesterase and results in impairment of Nef biological functions. J Virol 74: 5310-5319.
57. Piguet V, Gu F, Foti M, Demaurex N, Gruenberg J, et al. (1999) Nef-induced CD4 degradation: a diacidic-based motif in Nef functions as a lysosomal targeting signal through the binding of beta-COP in endosomes. Cell 97: 63-73.
58. Garcia JV, Alfano J, Miller AD, (1993) The negative effect of human immunodeficiency virus type 1 Nef on cell surface CD4 expression is not species specific and requires the cytoplasmic domain of CD4. J Virol 67: 1511-1516.
59. Geyer M, Yu H, Mandic R, Linnemann T, Zheng YH, et al. (2002) Subunit H of the V-ATPase binds to the medium chain of adaptor protein complex 2 and connects Nef to the endocytic machinery. J Biol Chem 277: 28521-28529.
60. Lenassi M, Cagney G, Liao M, Vaupotic T, Bartholomeeusen K, et al. (2010) HIV Nef is secreted in exosomes and triggers apoptosis in bystander CD4+ T cells. Traffic 11: 110-122.
61. James CO, Huang MB, Khan M, Garcia-Barrio M, Powell MD, et al. (2004) Extracellular Nef protein targets CD4+ T cells for apoptosis by interacting with CXCR4 surface receptors. J Virol 78: 3099-3109.
62. Qiao X, He B, Chiu A, Knowles DM, Chadburn A, et al. (2006) Human immunodeficiency virus 1 Nef suppresses CD40-dependent immunoglobulin class switching in bystander B cells. Nat Immunol 7: 302-310.
63. Cecchinato V, Tryniszewska E, Ma ZM, Vaccari M, Boasso A, et al. (2008) Immune activation driven by CTLA-4 blockade augments viral replication at mucosal sites in simian immunodeficiency virus infection. J Immunol 180: 5439-5447.